IBIO INC.      DL -,001
IBIO INC. DL -,001
Share · US4510337086 · IBIO · A3E2GR (XASE)
Overview Financial Indicators
0,84 EUR
3,16 % 0,03 EUR
Frankfurt (XNYS) · Current prices and charts at MoneyPeak
10.06.2025 18:08

Current Prices from IBIO INC. DL -,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
IBIO
USD
10.06.2025 18:08
0,96 USD
0,90 USD
+6,23 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
2,96 % 13,41 % 21,73 % -83,83 % -67,73 % -62,78 % -99,87 %

Company Profile for IBIO INC. DL -,001 Share

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.

Company Data

Name IBIO INC. DL -,001
Company iBio, Inc.
Symbol IBIO
Website https://www.ibioinc.com
Primary Exchange XASE Frankfurt
WKN A3E2GR
ISIN US4510337086
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Martin B. Brenner D.V.M., Ph.D.
Country United States of America
Currency EUR
Employees 0,0 T
Address 8800 HSC Parkway, 77807 Bryan
IPO Date 2008-08-19

ID Changes

Date From To
06.01.2011 IBPM IBIO

Ticker Symbols

Name Symbol
Frankfurt 0JV0.F
NYSE IBIO

More Shares

Investors who IBIO INC. DL -,001 hold also have the following shares in their portfolio:
FLEXSHARES STOXX GLOBAL ESG SELECT INDEX FUND
FLEXSHARES STOXX GLOBAL ESG SELECT INDEX FUND Fund
US TREASURY 2026    15.08
US TREASURY 2026 15.08 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025